Manganese Oxide Nanoparticles As MRI Contrast Agents In Tumor Multimodal Imaging And Therapy

References

• Herschman HR. Molecular imaging: looking at problems, seeing solutions. Science. 2003;302(5645):605–608. doi:10.1126/science.109058514576425
   PubMedGoogle Scholar
• Zhang K, Chen HR, Li P, et al. Marriage strategy of structure and composition designs for intensifying ultrasound & MR & CT trimodal contrast imaging. ACS Appl Mater Inter. 2015;7(33):18590–18599. doi:10.1021/acsami.5b04999
   PubMed Web of Science ®Google Scholar
• Weissleder R, Pittet MJ. Imaging in the era of molecular oncology. Nature. 2008;452(7187):580–589. doi:10.1038/nature0691718385732
   PubMed Web of Science ®Google Scholar
• Wang LHV, Hu S. Photoacoustic tomography: in vivo imaging from organelles to organs. Science. 2012;335(6075):1458–1462. doi:10.1126/science.121621022442475
   PubMed Web of Science ®Google Scholar
• Zhan YH, Shi SX, Ehlerding EB, et al. Radiolabeled, antibody-conjugated manganese oxide nanoparticles for tumor vasculature targeted positron emission tomography and magnetic resonance imaging. ACS Appl Mater Inter. 2017;9(44):38304–38312. doi:10.1021/acsami.7b12216
   PubMed Web of Science ®Google Scholar
• Sun C, Lee JSH, Zhang MQ. Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliver Rev. 2008;60(11):1252–1265. doi:10.1016/j.addr.2008.03.018
   PubMed Web of Science ®Google Scholar
• Na HB, Song IC, Hyeon T. Inorganic nanoparticles for MRI contrast agents. Adv Mater. 2009;21(21):2133–2148. doi:10.1002/adma.v21:21
   Web of Science ®Google Scholar
• Lei M, Fu C, Cheng X, et al. Activated surface charge-reversal manganese oxide nanocubes with high surface-to-volume ratio for accurate magnetic resonance tumor imaging. Adv Funct Mater. 2017;27(30):1700978. doi:10.1002/adfm.201700978
   Web of Science ®Google Scholar
• Balci NC, Semelka RC. Contrast agents for MR imaging of the liver. Radiol Clin N Am. 2005;43(5):887–898. doi:10.1016/j.rcl.2005.05.00416098345
   PubMed Web of Science ®Google Scholar
• Zhao Z, Zhou Z, Bao J, et al. Octapod iron oxide nanoparticles as high-performance T2 contrast agents for magnetic resonance imaging. Nat Commun. 2013;4:2266. doi:10.1038/ncomms326623903002
   PubMedGoogle Scholar
• Caravan P. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents. Chem Soc Rev. 2006;35(6):512–523. doi:10.1039/b510982p16729145
   PubMed Web of Science ®Google Scholar
• Idee JM, Port M, Dencausse A, Lancelot E, Corot C. Involvement of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: an update. Radiol Clin N Am. 2009;47(5):855–869. doi:10.1016/j.rcl.2009.06.00619744600
   PubMedGoogle Scholar
• Thomsen HS, Morcos SK, Almen T, et al. Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines. Eur Radiol. 2013;23(2):307–318. doi:10.1007/s00330-012-2597-922865271
   PubMedGoogle Scholar
• Xiang Y, Li NL, Guo LJ, et al. Biocompatible and pH-sensitive MnO-loaded carbonaceous nanospheres (MnO@CNSs): a theranostic agent for magnetic resonance imaging-guided photothermal therapy. Carbon. 2018;136:113–124. doi:10.1016/j.carbon.2018.04.058
   Web of Science ®Google Scholar
• Bulte JWM. In vivo MRI cell tracking: clinical studies. Am J Roentgenol. 2009;193(2):314–325. doi:10.2214/AJR.09.310719620426
   PubMed Web of Science ®Google Scholar
• Kostura L, Kraitchman DL, Mackay AM, Pittenger MF, Bulte JWM. Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed. 2004;17(7):513–517. doi:10.1002/nbm.92515526348
   PubMed Web of Science ®Google Scholar
• Neves HR, Bini RA, Barbosa JHO, Salmon CEG, Varanda LC. Dextran-coated antiferromagnetic MnO nanoparticles for a T-1-MRI contrast agent with high colloidal stability. Part Part Syst Char. 2016;33(3):167–176. doi:10.1002/ppsc.201500251
   Web of Science ®Google Scholar
• Hu H, Liu SL, Li D, et al. The synthesis of lanthanide-doped GdVO4 ultrathin nanosheets with great optical and paramagnetic properties for FRET biodetection and in vivo MR imaging. J Mater Chem B. 2014;2(25):3998–4007. doi:10.1039/C4TB00144C
   PubMed Web of Science ®Google Scholar
• Fitsanakis VA, Zhang N, Avison MJ, Gore JC, Aschner JL, Aschner M. The use of magnetic resonance imaging (MRI) in the study of manganese neurotoxicity. Neurotoxicology. 2006;27(5):798–806. doi:10.1016/j.neuro.2006.03.00116620989
   PubMed Web of Science ®Google Scholar
• Takeda A. Manganese action in brain function. Brain Res Rev. 2003;41(1):79–87.12505649
   PubMed Web of Science ®Google Scholar
• Guilarte TR. Manganese neurotoxicity: new perspectives from behavioral, neuroimaging, and neuropathological studies in humans and non-human primates. Front Aging Neurosci. 2013;5:23. doi:10.3389/fnagi.2013.0002323805100
   PubMedGoogle Scholar
• Pan D, Caruthers SD, Hu G, et al. Ligand-directed nanobialys as theranostic agent for drug delivery and manganese-based magnetic resonance Imaging of vascular targets. J Am Chem Soc. 2008;130(29):9186–9187. doi:10.1021/ja801482d18572935
   PubMed Web of Science ®Google Scholar
• Pan DPJ, Schmieder AH, Wickline SA, Lanza GM. Manganese-based MRI contrast agents: past, present, and future. Tetrahedron. 2011;67(44):8431–8444. doi:10.1016/j.tet.2011.07.07622043109
   PubMed Web of Science ®Google Scholar
• Peng JR, Dong ML, Ran B, et al. “One-for-AII”-type, biodegradable prussian blue/manganese dioxide hybrid nanocrystal for trimodal imaging-guided photothermal therapy and oxygen regulation of breast cancer. ACS Appl Mater Inter. 2017;9(16):13875–13886. doi:10.1021/acsami.7b01365
   PubMed Web of Science ®Google Scholar
• Hsu BYW, Kirby G, Tan A, Seifalian AM, Li X, Wang J. Relaxivity and toxicological properties of manganese oxide nanoparticles for MRI applications. RSC Adv. 2016;6(51):45462–45474. doi:10.1039/C6RA04421B31156805
   PubMedGoogle Scholar
• Garcia-Hevia L, Banobre-Lopez M, Gallo J. Recent progress on manganese-based nanostructures as responsive MRI contrast agents. Chem-Eur J. 2019;25(2):431–441. doi:10.1002/chem.20180285129999200
   PubMedGoogle Scholar
• Li J, Wu C, Hou P, Zhang M, Xu K. One-pot preparation of hydrophilic manganese oxide nanoparticles as T1 nano-contrast agent for molecular magnetic resonance imaging of renal carcinoma in vitro and in vivo. Biosens Bioelectron. 2018;102:1–8. doi:10.1016/j.bios.2017.10.04729101783
   PubMed Web of Science ®Google Scholar
• Huang HT, Yue T, Xu K, Golzarian J, Yu JH, Huang J. Fabrication and evaluation of tumor-targeted positive MRI contrast agent based on ultrasmall MnO nanoparticles. Colloid Surf B. 2015;131:148–154.
   PubMed Web of Science ®Google Scholar
• Hsu BYW, Wang M, Zhang Y, et al. Silica-F127 nanohybrid-encapsulated manganese oxide nanoparticles for optimized T-1 magnetic resonance relaxivity. Nanoscale. 2014;6(1):293–299. doi:10.1039/c3nr04378a24193096
   PubMedGoogle Scholar
• Costanzo M, Scolaro L, Berlier G, et al. Cell uptake and intracellular fate of phospholipidic manganese-based nanoparticles. Int J Pharmaceut. 2016;508(1–2):83–91. doi:10.1016/j.ijpharm.2016.05.019
   PubMed Web of Science ®Google Scholar
• Chevallier P, Walter A, Garofalo A, et al. Tailored biological retention and efficient clearance of pegylated ultra-small MnO nanoparticles as positive MRI contrast agents for molecular imaging. J Mater Chem B. 2014;2(13):1779–1790. doi:10.1039/C3TB21634A
   PubMed Web of Science ®Google Scholar
• Huang HT, Yue T, Xu YY, et al. PEGylation of MnO nanoparticles via catechol-Mn chelation to improving T-1-weighted magnetic resonance imaging application. J Appl Polym Sci. 2015;132(31):42360. doi:10.1002/app.42360
   Web of Science ®Google Scholar
• Gallo J, Alam IS, Lavdas I, Wylezinska-Arridge M, Aboagye EO, Long NJ. RGD-targeted MnO nanoparticles as T1contrast agents for cancer imaging – the effect of PEG length in vivo. J Mater Chem B. 2014;2(7):868–876. doi:10.1039/C3TB21422B
   PubMed Web of Science ®Google Scholar
• Chen N, Shao C, Qu Y, et al. Folic acid-conjugated MnO nanoparticles as a T1 contrast agent for magnetic resonance imaging of tiny brain gliomas. ACS Appl Mater Interfaces. 2014;6(22):19850–19857. doi:10.1021/am505223t25335117
   PubMedGoogle Scholar
• Hu X, Ji Y, Wang M, et al. Water-soluble and biocompatible MnO@PVP nanoparticles for MR imaging in vitro and in vivo. J Biomed Nanotechnol. 2013;9(6):976–984. doi:10.1166/jbn.2013.160223858961
   PubMedGoogle Scholar
• Douglas FJ, MacLaren DA, Tuna F, Holmes WM, Berry CC, Murrie M. Formation of octapod MnO nanoparticles with enhanced magnetic properties through kinetically-controlled thermal decomposition of polynuclear manganese complexes. Nanoscale. 2014;6(1):172–176. doi:10.1039/c3nr04832b24220037
   PubMedGoogle Scholar
• Peng YK, Lui CNP, Chen YW, et al. Engineering of single magnetic particle carrier for living brain cell imaging: a tunable T-1-/T-2-/dual-modal contrast agent for magnetic resonance imaging application. Chem Mater. 2017;29(10):4411–4417. doi:10.1021/acs.chemmater.7b00884
   Web of Science ®Google Scholar
• Peng E, Wang FH, Tan SH, Zheng BW, Li SFY, Xue JM. Tailoring a two-dimensional graphene oxide surface: dual T-1 and T-2 MRI contrast agent materials. J Mater Chem B. 2015;3(28):5678–5682. doi:10.1039/C5TB00902B
   PubMed Web of Science ®Google Scholar
• Zheng YY, Zhang H, Hu YP, Bai L, Xue JY. MnO nanoparticles with potential application in magnetic resonance imaging and drug delivery for myocardial infarction. Int J Nanomed. 2018;13:6177–6188. doi:10.2147/IJN.S176404
   PubMed Web of Science ®Google Scholar
• Chen N, Shao C, Li S, et al. Cy5.5 conjugated MnO nanoparticles for magnetic resonance/near-infrared fluorescence dual-modal imaging of brain gliomas. J Colloid Interf Sci. 2015;457:27–34. doi:10.1016/j.jcis.2015.06.046
   PubMed Web of Science ®Google Scholar
• Hsu BYW, Ng M, Tan A, et al. pH-activatable MnO-based fluorescence and magnetic resonance bimodal nanoprobe for cancer imaging. Adv Healthc Mater. 2016;5(6):721–729. doi:10.1002/adhm.20150090826895111
   PubMedGoogle Scholar
• Lai JX, Wang TJ, Wang H, Shi FQ, Gu W, Ye L. MnO nanoparticles with unique excitation-dependent fluorescence for multicolor cellular imaging and MR imaging of brain glioma. Microchim Acta. 2018;185(4):244. doi:10.1007/s00604-018-2779-5
   PubMed Web of Science ®Google Scholar
• Banerjee A, Bertolesi GE, Ling CC, et al. Bifunctional pyrrolidin-2-one terminated manganese oxide nanoparticles for combined magnetic resonance and fluorescence imaging. ACS Appl Mater Interfaces. 2019;11(14):13069–13078. doi:10.1021/acsami.8b2176230883086
   PubMedGoogle Scholar
• Li S, Shao C, Gu W, et al. Targeted imaging of brain gliomas using multifunctional Fe3O4/MnO nanoparticles. RSC Adv. 2015;5(42):33639–33645. doi:10.1039/C5RA01069A
   Web of Science ®Google Scholar
• Liu Y, Lv XL, Liu H, et al. Porous gold nanocluster-decorated manganese monoxide nanocomposites for microenvironment-activatable MR/photoacoustic/CT tumor imaging. Nanoscale. 2018;10(8):3631–3638. doi:10.1039/c7nr08535d29412212
   PubMedGoogle Scholar
• Liu JN, Bu WB, Shi JL. Chemical design and synthesis of functionalized probes for imaging and treating tumor hypoxia. Chem Rev. 2017;117(9):6160–6224. doi:10.1021/acs.chemrev.6b0052528426202
   PubMed Web of Science ®Google Scholar
• Ni DL, Jiang DW, Valdovinos HF, et al. Bioresponsive polyoxometalate cluster for redox-activated photoacoustic imaging-guided photothermal cancer therapy. Nano Lett. 2017;17(5):3282–3289. doi:10.1021/acs.nanolett.7b0099528418679
   PubMed Web of Science ®Google Scholar
• Lu Y, Zhang L, Li J, et al. MnO nanocrystals: a platform for integration of MRI and genuine autophagy induction for chemotherapy. Adv Funct Mater. 2013;23(12):1534–1546. doi:10.1002/adfm.201202233
   Web of Science ®Google Scholar
• Wei J, Yu C, Wang L, et al. Cytotoxicity of mitochondrial-targeting silica-coated manganese oxide nanoparticles. Sci China Chem. 2015;58(10):1537–1543. doi:10.1007/s11426-015-5374-1
   Web of Science ®Google Scholar
• Howell M, Mallela J, Wang C, et al. Manganese-loaded lipid-micellar theranostics for simultaneous drug and gene delivery to lungs. J Control Release. 2013;167(2):210–218. doi:10.1016/j.jconrel.2013.01.02923395689
   PubMedGoogle Scholar
• Wang D, Lin H, Zhang G, et al. Effective pH-activated theranostic platform for synchronous magnetic resonance imaging diagnosis and chemotherapy. ACS Appl Mater Inter. 2018;10(37):31114–31123. doi:10.1021/acsami.8b11408
   PubMed Web of Science ®Google Scholar
• Abbasi AZ, Prasad P, Cai P, et al. Manganese oxide and docetaxel co-loaded fluorescent polymer nanoparticles for dual modal imaging and chemotherapy of breast cancer. J Control Release. 2015;209:186–196. doi:10.1016/j.jconrel.2015.04.02025908171
   PubMed Web of Science ®Google Scholar
• Wang S, Zhang Q, Yang P, et al. Manganese oxide-coated carbon nanotubes as dual-modality lymph mapping agents for photothermal therapy of tumor metastasis. ACS Appl Mater Interfaces. 2016;8(6):3736–3743. doi:10.1021/acsami.5b0808726653008
   PubMedGoogle Scholar
• Zhou LH, Wu YY, Meng XQ, et al. Dye-anchored MnO nanoparticles targeting tumor and inducing enhanced phototherapy effect via mitochondria-mediated pathway. Small. 2018;14(36):1801008. doi:10.1002/smll.201801008
   Web of Science ®Google Scholar
• He DG, He XX, Wang KM, et al. Redox-responsive degradable honeycomb manganese oxide nanostructures as effective nanocarriers for intracellular glutathione-triggered drug release. Chem Commun. 2015;51(4):776–779. doi:10.1039/C4CC08172B
   PubMed Web of Science ®Google Scholar
• Hu H, Dai AT, Sun J, et al. Aptamer-conjugated Mn3O4@SiO2 core-shell nanoprobes for targeted magnetic resonance imaging. Nanoscale. 2013;5(21):10447–10454. doi:10.1039/c3nr03490a24057072
   PubMedGoogle Scholar
• Yang X, Zhou Z, Wang L, Tang C, Yang H, Yang S. Folate conjugated Mn3O4@SiO2 nanoparticles for targeted magnetic resonance imaging in vivo. Mater Res Bull. 2014;57:97–102. doi:10.1016/j.materresbull.2014.05.023
   Web of Science ®Google Scholar
• Wang P, Yang J, Zhou BQ, et al. Antifouling manganese oxide nanoparticles: synthesis, characterization, and applications for enhanced MR imaging of tumors. ACS Appl Mater Inter. 2017;9(1):47–53. doi:10.1021/acsami.6b13844
   PubMed Web of Science ®Google Scholar
• Luo Y, Yang J, Li J, et al. Facile synthesis and functionalization of manganese oxide nanoparticles for targeted T1-weighted tumor MR imaging. Colloids and Surf B Biointerfaces. 2015;136:506–513. doi:10.1016/j.colsurfb.2015.09.05326454057
   PubMedGoogle Scholar
• Sun W, Zhang J, Zhang C, et al. Construction of hybrid alginate nanogels loaded with manganese oxide nanoparticles for enhanced tumor magnetic resonance imaging. ACS Macro Lett. 2018;7(2):137–142. doi:10.1021/acsmacrolett.7b00999
   PubMed Web of Science ®Google Scholar
• Lee J, Kumari N, Kim SM, et al. Anchoring ligand-effect on bright contrast-enhancing property of hollow Mn3O4 nanoparticle in T1-weighted magnetic resonance imaging. Chem Mater. 2018;30(12):4056–4064. doi:10.1021/acs.chemmater.8b00854
   Web of Science ®Google Scholar
• Guo W, Qi Y, Zhang Y, Ma L, Yu D, Zhan J. Biocompatible caramelized carbonaceous nanospheres supported paramagnetic ultrathin manganese oxide nanosheets via self-sacrificing reduction as a MRI contrast agent for liver imaging. Carbon. 2016;110:321–329. doi:10.1016/j.carbon.2016.09.030
   Web of Science ®Google Scholar
• Xiao J, Tian XM, Yang C, et al. Ultrahigh relaxivity and safe probes of manganese oxide nanoparticles for in vivo imaging. Sci Rep. 2013;3:3424. doi:10.1038/srep0342424305731
   PubMedGoogle Scholar
• Hu H, Zhang C, An L, et al. General protocol for the synthesis of functionalized magnetic nanoparticles for magnetic resonance imaging from protected metal-organic precursors. Chemistry. 2014;20(23):7160–7167. doi:10.1002/chem.20130507224771671
   PubMedGoogle Scholar
• Li JC, Hu Y, Sun WJ, Luo Y, Shi XY, Shen MW. Facile preparation of hyaluronic acid-modified Fe3O4@Mn3O4 nanocomposites for targeted T-1/T-2 dual-mode MR imaging of cancer cells. RSC Adv. 2016;6(42):35295–35304. doi:10.1039/C6RA05648B
   Web of Science ®Google Scholar
• Kim MH, Son HY, Kim GY, Park K, Huh YM, Haam S. Redoxable heteronanocrystals functioning magnetic relaxation switch for activatable T-1 and T-2 dual-mode magnetic resonance imaging. Biomaterials. 2016;101:121–130. doi:10.1016/j.biomaterials.2016.05.05427281684
   PubMedGoogle Scholar
• Zhu JY, Li HS, Xiong ZJ, et al. Polyethyleneimine-coated manganese oxide nanoparticles for targeted tumor PET/MR imaging. ACS Appl Mater Inter. 2018;10(41):34954–34964. doi:10.1021/acsami.8b12355
   PubMed Web of Science ®Google Scholar
• Fonsatti E, Nicolay HJM, Altomonte M, Covre A, Maio M. Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours. Cardiovasc Res. 2010;86(1):12–19. doi:10.1093/cvr/cvp33219812043
   PubMedGoogle Scholar
• Zhan Y, Ehlerding EB, Shi S, et al. Intrinsically zirconium-89-labeled manganese oxide nanoparticles for in vivo dual-modality positron emission tomography and magnetic resonance imaging. J Biomed Nanotechnol. 2018;14(5):900–909. doi:10.1166/jbn.2018.249829883560
   PubMedGoogle Scholar
• Zhan Y, Zhan W, Li H, et al. In vivo dual-modality fluorescence and magnetic resonance imaging-guided lymph node mapping with good biocompatibility manganese oxide nanoparticles. Molecules. 2017;22(12):2208. doi:10.3390/molecules22122208
   PubMed Web of Science ®Google Scholar
• Fang C, Zhang M. Nanoparticle-based theragnostics: integrating diagnostic and therapeutic potentials in nanomedicine. J Control Release. 2010;146(1):2–5. doi:10.1016/j.jconrel.2010.05.01320493220
   PubMedGoogle Scholar
• Wang A, Guo M, Wang N, et al. Redox-mediated dissolution of paramagnetic nanolids to achieve a smart theranostic system. Nanoscale. 2014;6(10):5270–5278. doi:10.1039/c3nr05687b24695417
   PubMedGoogle Scholar
• Zhang Y, Tan J, Long M, et al. An emerging dual collaborative strategy for high-performance tumor therapy with mesoporous silica nanotubes loaded with Mn3O4. J Mater Chem B. 2016;4(46):7406–7414. doi:10.1039/C6TB01788F
   PubMed Web of Science ®Google Scholar
• Agostinis P, Berg K, Cengel KA, et al. Photodynamic therapy of cancer: an update. CA Cancer J Clin. 2011;61(4):250–281. doi:10.3322/caac.2011421617154
   PubMed Web of Science ®Google Scholar
• Nafiujjaman M, Nurunnabi M, Kang S-H, Reeck GR, Khan HA, Lee Y-K. Ternary graphene quantum dot–polydopamine–mn3O4 nanoparticles for optical imaging guided photodynamic therapy and T1-weighted magnetic resonance imaging. J Mater Chem B. 2015;3(28):5815–5823. doi:10.1039/C5TB00479A
   PubMed Web of Science ®Google Scholar
• Ding X, Liu JH, JQ L, et al. Polydopamine coated manganese oxide nanoparticles with ultrahigh relaxivity as nanotheranostic agents for magnetic resonance imaging guided synergetic chemo-/photothermal therapy. Chem Sci. 2016;7(11):6695–6700. doi:10.1039/c6sc01320a28451112
   PubMedGoogle Scholar
• Liu Y, Zhang G, Guo Q, et al. Artificially controlled degradable inorganic nanomaterial for cancer theranostics. Biomaterials. 2017;112:204–217. doi:10.1016/j.biomaterials.2016.10.02827768974
   PubMedGoogle Scholar
• Szatrowski TP, Nathan CF. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res. 1991;51(3):794–798.1846317
   PubMed Web of Science ®Google Scholar
• Xu J, Han W, Yang P, et al. Tumor microenvironment-responsive mesoporous MnO2-coated upconversion nanoplatform for self-enhanced tumor theranostics. Adv Funct Mater. 2018;28(36):1803804. doi:10.1002/adfm.201803804
   Web of Science ®Google Scholar
• Lin LS, Song JB, Song L, et al. Simultaneous fenton-like ion delivery and glutathione depletion by MnO2-based nanoagent to enhance chemodynamic therapy. Angew Chem Int Edit. 2018;57(18):4902–4906. doi:10.1002/anie.201712027
   PubMed Web of Science ®Google Scholar
• Evans SM, Koch CJ. Prognostic significance of tumor oxygenation in humans. Cancer Lett. 2003;195(1):1–16. doi:10.1016/s0304-3835(03)00012-012767506
   PubMedGoogle Scholar
• Zhao ZL, Fan HH, Zhou GF, et al. Activatable fluorescence/MRI bimodal platform for tumor cell imaging via MnO2 nanosheet-aptamer nanoprobe. J Am Chem Soc. 2014;136(32):11220–11223. doi:10.1021/ja502936425061849
   PubMed Web of Science ®Google Scholar
• Shi W, Song B, Shi W, et al. Bimodal phosphorescence-magnetic resonance imaging nanoprobes for glutathione based on MnO2 nanosheet-Ru(II) complex nanoarchitecture. ACS Appl Mater Interfaces. 2018;10(33):27681–27691. doi:10.1021/acsami.8b0887230058801
   PubMedGoogle Scholar
• Duan B, Wang D, Wu H, et al. Core–shell structurized Fe3O4@C@MnO2 nanoparticles as pH responsive T1-T2* dual-modal contrast agents for tumor diagnosis. ACS Biomater Sci Eng. 2018;4(8):3047–3054. doi:10.1021/acsbiomaterials.8b00287
   PubMed Web of Science ®Google Scholar
• Eubank TD, Roberts RD, Khan M, et al. Granulocyte macrophage colony-stimulating factor inhibits breast cancer growth and metastasis by invoking an anti-angiogenic program in tumor-educated macrophages. Cancer Res. 2009;69(5):2133–2140. doi:10.1158/0008-5472.CAN-08-140519223554
   PubMedGoogle Scholar
• Chen Y, Ye D, Wu M, et al. Break-up of two-dimensional MnO2 nanosheets promotes ultrasensitive pH-triggered theranostics of cancer. Adv Mater. 2014;26(41):7019–7026. doi:10.1002/adma.20140257225156250
   PubMed Web of Science ®Google Scholar
• Song M, Liu T, Shi C, Zhang X, Chen X. Bioconjugated manganese dioxide nanoparticles enhance chemotherapy response by priming tumor-associated macrophages toward M1-like phenotype and attenuating tumor hypoxia. ACS Nano. 2016;10(1):633–647. doi:10.1021/acsnano.5b0677926650065
   PubMed Web of Science ®Google Scholar
• Hao Y, Wang L, Zhang B, et al. Manganese dioxide nanosheets-based redox/pH-responsive drug delivery system for cancer theranostic application. Int J Nanomedicine. 2016;11:1759–1778. doi:10.2147/IJN.S9883227199556
   PubMedGoogle Scholar
• Hao Y, Wang L, Zhang B, et al. Multifunctional nanosheets based on folic acid modified manganese oxide for tumor-targeting theranostic application. Nanotechnology. 2016;27(2):025101. doi:10.1088/0957-4484/27/36/36520226629735
   PubMedGoogle Scholar
• Pan J, Wang Y, Pan H, et al. Mimicking drug-substrate interaction: a smart bioinspired technology for the fabrication of theranostic nanoprobes. Adv Funct Mater. 2017;27(3):1603440. doi:10.1002/adfm.201603440
   Web of Science ®Google Scholar
• Zhang M, Xing L, Ke H, et al. MnO2-based nanoplatform serves as drug vehicle and MRI contrast agent for cancer theranostics. ACS Appl Mater Interfaces. 2017;9(13):11337–11344. doi:10.1021/acsami.6b1524728291320
   PubMed Web of Science ®Google Scholar
• Meng L, Cheng Y, Gan S, et al. Facile deposition of manganese dioxide to albumin-bound paclitaxel nanoparticles for modulation of hypoxic tumor microenvironment to improve chemoradiation therapy. Mol Pharm. 2018;15(2):447–457. doi:10.1021/acs.molpharmaceut.7b0080829261319
   PubMed Web of Science ®Google Scholar
• Shi Y, Guenneau F, Wang X, Helary C, Coradin T. MnO2-gated nanoplatforms with targeted controlled drug release and contrast-enhanced MRI properties: from 2D cell culture to 3D biomimetic hydrogels. Nanotheranostics. 2018;2(4):403–416. doi:10.7150/ntno.2804630324085
   PubMedGoogle Scholar
• Wu Y, Li D, Zhou F, et al. Versatile in situ synthesis of MnO2 nanolayers on upconversion nanoparticles and their application in activatable fluorescence and MRI imaging. Chem Sci. 2018;9(24):5427–5434. doi:10.1039/c8sc00490k30009014
   PubMedGoogle Scholar
• Song R, Zhang M, Liu Y, et al. A multifunctional nanotheranostic for the intelligent MRI diagnosis and synergistic treatment of hypoxic tumor. Biomaterials. 2018;175:123–133. doi:10.1016/j.biomaterials.2018.05.01829804000
   PubMedGoogle Scholar
• Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer. 2002;2(1):48–58. doi:10.1038/nrc70611902585
   PubMed Web of Science ®Google Scholar
• Zhang C, Bu WB, Ni DL, et al. Synthesis of iron nanometallic glasses and their application in cancer therapy by a localized fenton reaction. Angew Chem Int Edit. 2016;55(6):2101–2106. doi:10.1002/anie.201510031
   PubMed Web of Science ®Google Scholar
• Turan IS, Yildiz D, Turksoy A, Gunaydin G, Akkaya EU. A bifunctional photosensitizer for enhanced fractional photodynamic therapy: singlet oxygen generation in the presence and absence of light. Angew Chem Int Edit. 2016;55(8):2875–2878. doi:10.1002/anie.201511345
   PubMed Web of Science ®Google Scholar
• Hao Y, Zhang B, Zheng C, et al. Multifunctional nanoplatform for enhanced photodynamic cancer therapy and magnetic resonance imaging. Colloids and Surf B Biointerfaces. 2017;151:384–393. doi:10.1016/j.colsurfb.2016.10.03928029550
   PubMed Web of Science ®Google Scholar
• Meng HM, Lu LM, Zhao XH, et al. Multiple functional nanoprobe for contrast-enhanced bimodal cellular imaging and targeted therapy. Anal Chem. 2015;87(8):4448–4454. doi:10.1021/acs.analchem.5b0033725791340
   PubMedGoogle Scholar
• Chu CC, Lin HR, Liu H, et al. Tumor microenvironment-triggered supramolecular system as an in situ nanotheranostic generator for cancer phototherapy. Adv Mater. 2017;29(23):1605928. doi:10.1002/adma.201700681
   Web of Science ®Google Scholar
• Sun QQ, He F, Sun CQ, et al. Honeycomb-satellite structured pH/H2O2-responsive degradable nanoplatform for efficient photodynamic therapy and multimodal imaging. ACS Appl Mater Inter. 2018;10(40):33901–33912. doi:10.1021/acsami.8b10207
   PubMed Web of Science ®Google Scholar
• Liu H, Liu Y, Chu CC, et al. Intelligent albumin-stabilized manganese dioxide nanocomposites for tumor microenvironment responsive phototherapy. J Biomed Nanotechnol. 2017;13(10):1321–1332. doi:10.1166/jbn.2017.2450
   Web of Science ®Google Scholar
• Lin T, Zhao X, Zhao S, et al. O2-generating MnO2 nanoparticles for enhanced photodynamic therapy of bladder cancer by ameliorating hypoxia. Theranostics. 2018;8(4):990–1004. doi:10.7150/thno.2246529463995
   PubMed Web of Science ®Google Scholar
• Ma Z, Jia X, Bai J, et al. MnO2Gatekeeper: an Intelligent and O2-evolving shell for preventing premature release of high cargo payload core, overcoming tumor hypoxia, and acidic H2O2-sensitive MRI. Adv Funct Mater. 2017;27(4):1604258. doi:10.1002/adfm.201604258
   Web of Science ®Google Scholar
• Liu J, Du P, Liu T, et al. A black phosphorus/manganese dioxide nanoplatform: oxygen self-supply monitoring, photodynamic therapy enhancement and feedback. Biomaterials. 2019;192:179–188. doi:10.1016/j.biomaterials.2018.10.01830453214
   PubMedGoogle Scholar
• He ZM, Xiao Y, Zhang JR, Zhang PH, Zhu JJ. In situ formation of large pore silica-MnO2 nanocomposites with H+/H2O2 sensitivity for O-2-elevated photodynamic therapy and potential MR imaging. Chem Commun. 2018;54(24):2962–2965. doi:10.1039/C7CC09532E
   PubMed Web of Science ®Google Scholar
• Zhu W, Zhang L, Yang Z, et al. An efficient tumor-inducible nanotheranostics for magnetic resonance imaging and enhanced photodynamic therapy. Chem Eng J. 2019;358:969–979. doi:10.1016/j.cej.2018.10.102
   Web of Science ®Google Scholar
• Liang RJ, Liu LL, He HM, et al. Oxygen-boosted immunogenic photodynamic therapy with gold nanocages@manganese dioxide to inhibit tumor growth and metastases. Biomaterials. 2018;177:149–160. doi:10.1016/j.biomaterials.2018.05.05129890364
   PubMed Web of Science ®Google Scholar
• Hao YW, Zhang BX, Zheng CX, et al. Multifunctional nanoplatform for enhanced photodynamic cancer therapy and magnetic resonance imaging. Colloid Surf B. 2017;151:384–393. doi:10.1016/j.colsurfb.2016.10.039
   PubMed Web of Science ®Google Scholar
• Hu DR, Chen LJ, Qu Y, et al. Oxygen-generating hybrid polymeric nanoparticles with encapsulated doxorubicin and chlorin e6 for trimodal imaging-guided combined chemo-photodynamic therapy. Theranostics. 2018;8(6):1558–1574. doi:10.7150/thno.2298929556341
   PubMed Web of Science ®Google Scholar
• Xu JT, Han W, Yang PP, et al. Tumor microenvironment-responsive mesoporous MnO2-coated upconversion nanoplatform for self-enhanced tumor theranostics. Adv Funct Mater. 2018;28(36):1803804. doi:10.1002/adfm.201803804
   Web of Science ®Google Scholar
• Bi HT, Dai YL, Yang PP, et al. Glutathione and H2O2 consumption promoted photodynamic and chemotherapy based on biodegradable MnO2-Pt@Au-25 nanosheets. Chem Eng J. 2019;356:543–553. doi:10.1016/j.cej.2018.09.076
   Web of Science ®Google Scholar
• Zhang C, Chen W-H, Liu L-H, Qiu W-X, Yu W-Y, Zhang X-Z. An O2 self-supplementing and reactive-oxygen-species-circulating amplified nanoplatform via H2O/H2O2 splitting for tumor imaging and photodynamic therapy. Adv Funct Mater. 2017;27(43):1700626. doi:10.1002/adfm.v27.43
   Web of Science ®Google Scholar
• Deng YY, Li ED, Cheng XJ, et al. Facile preparation of hybrid core-shell nanorods for photothermal and radiation combined therapy. Nanoscale. 2016;8(7):3895–3899. doi:10.1039/c5nr09102k26818657
   PubMedGoogle Scholar
• Fan WP, Yung B, Huang P, Chen XY. Nanotechnology for multimodal synergistic cancer therapy. Chem Rev. 2017;117(22):13566–13638. doi:10.1021/acs.chemrev.7b0025829048884
   PubMed Web of Science ®Google Scholar
• Chen XY, Gambhlr SS, Cheon J. Theranostic Nanomedicine. Accounts Chem Res. 2011;44(10):841. doi:10.1021/ar200231d
   PubMedGoogle Scholar
• Liu Z, Zhang SJ, Lin H, et al. Theranostic 2D ultrathin MnO2 nanosheets with fast responsibility to endogenous tumor microenvironment and exogenous NIR irradiation. Biomaterials. 2018;155:54–63. doi:10.1016/j.biomaterials.2017.11.01529169038
   PubMed Web of Science ®Google Scholar
• Fu DD, Ding XG, Wu J, Li CY, Wang QB, Jiang J. Cationic polyelectrolyte mediated synthesis of mno2-based core-shell structures as activatable MRI theranostic platform for tumor cell ablation. Part Part Syst Char. 2018;35(7):1800078. doi:10.1002/ppsc.201800078
   Web of Science ®Google Scholar
• Cai XJ, Gao W, Ma M, et al. A Prussian blue-based core-shell hollow-structured mesoporous nanoparticle as a smart theranostic agent with ultrahigh pH-responsive longitudinal relaxivity. Adv Mater. 2015;27(41):6382–6389. doi:10.1002/adma.20150338126393889
   PubMed Web of Science ®Google Scholar
• Chen WH, Luo GF, Lei Q, et al. Overcoming the heat endurance of tumor cells by interfering with the anaerobic glycolysis metabolism for improved photothermal therapy. ACS Nano. 2017;11(2):1419–1431. doi:10.1021/acsnano.6b0665828107631
   PubMed Web of Science ®Google Scholar
• Jin LH, Liu JH, Tang Y, et al. MnO2-functionalized Co-P nanocomposite: a new theranostic agent for pH-triggered T-1/T-2 dual-modality magnetic resonance imaging-guided chemo-photothermal synergistic therapy. ACS Appl Mater Inter. 2017;9(48):41648–41658. doi:10.1021/acsami.7b10608
   PubMed Web of Science ®Google Scholar
• Li SN, Zhang LY, Chen XJ, et al. Selective growth synthesis of ternary janus nanoparticles for imaging-guided synergistic chemo- and photothermal therapy in the second NIR window. ACS Appl Mater Inter. 2018;10(28):24137–24148. doi:10.1021/acsami.8b06527
   PubMed Web of Science ®Google Scholar
• Zhang TT, Xu CH, Zhao W, et al. A redox-activated theranostic nanoagent: toward multi-mode imaging guided chemo-photothermal therapy. Chem Sci. 2018;9(33):6749–6757. doi:10.1039/c8sc02446d30310607
   PubMedGoogle Scholar
• Yang GB, Zhang R, Liang C, et al. Manganese dioxide coated WS2@Fe3O4/sSiO(2) nanocomposites for pH-responsive MR imaging and oxygen-elevated synergetic therapy. Small. 2018;14(2):1702664. doi:10.1002/smll.201702664
   Web of Science ®Google Scholar
• Cao Y, Meng XD, Wang DD, et al. Intelligent MnO2/Cu2-xS for multimode imaging diagnostic and advanced single-laser irradiated photothermal/photodynamic therapy. ACS Appl Mater Inter. 2018;10(21):17732–17741. doi:10.1021/acsami.8b05050
   PubMed Web of Science ®Google Scholar
• Rosenholm JM, Korpi RM, Lammentausta E, et al. Novel, fast-processed crystalline and amorphous manganese oxide nanoparticles for stem cell labeling. Inorg Chem Front. 2015;2(7):640–648. doi:10.1039/C5QI00033E
   Web of Science ®Google Scholar
• Ren SS, Yang J, Ma L, et al. Ternary-responsive drug delivery with activatable dual mode contrast-enhanced in vivo imaging. ACS Appl Mater Inter. 2018;10(38):31947–31958. doi:10.1021/acsami.8b10564
   PubMed Web of Science ®Google Scholar
• Gao H, Liu X, Tang W, et al. (99m)Tc-conjugated manganese-based mesoporous silica nanoparticles for SPECT, pH-responsive MRI and anti-cancer drug delivery. Nanoscale. 2016;8(47):19573–19580. doi:10.1039/c6nr07062k27874119
   PubMedGoogle Scholar
• Zhang SJ, Qian XQ, Zhang LL, Peng WJ, Chen Y. Composition-property relationships in multifunctional hollow mesoporous carbon nanosystems for PH-responsive magnetic resonance imaging and on-demand drug release. Nanoscale. 2015;7(17):7632–7643. doi:10.1039/c5nr00451a25785502
   PubMed Web of Science ®Google Scholar
• Dai C, Chen Y, Jing XX, et al. Two-dimensional tantalum carbide (MXenes) composite nanosheets for multiple imaging-guided photothermal tumor ablation. ACS Nano. 2017;11(12):12696–12712. doi:10.1021/acsnano.7b0724129156126
   PubMedGoogle Scholar